Imaging In-Depth Focus 2017
This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...
List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...
A network of hospitals have systematically collected biopsies from metastatic cancer patients in order to create a global database...
Advanced 2D imaging and analysis help scientists rapidly trace anatomical and molecular aspects of diseases to advance drug discovery...
Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...
Scientists have synthesised a complex sugar structure that specifically binds to the tumour protein Galectin-1...
11 August 2017 | By DiscoverX
In this webinar, DiscoverX Corporation discuss three negative allosteric modulators of metabotropic glutamate receptors, developed by Pfizer, which recently failed in preclinical development due to delayed type IV skin hypersensitivity observed in non-human primates...
A provider of products and services for research in stem cells, drug discovery, human tissues and 3D cell culture has opened its European headquarters in Glasgow, UK...
Researchers have tested samples of N. gonorrhoeae from patients with infections in the throat, urethra, cervix and rectum, they found that at very low amounts closthioamide was effective...
The Medical Research Council has formed partnerships with UCB and AstraZeneca, the deals will help speed translation of discovery research into potential therapies...
Prior to joining CRT-DL, Dr Ryder held positions in pharmaceutical and biotech companies for over 20 years ...
Evidence that the activation of a biological pathway necroptosis is closely linked with Alzheimer's...
Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
Cancer research at the University of Warwick has received a boost thanks to the former Lord Mayor of Coventry Cllr Lindsley Harvard.
Researchers at the University of Birmingham have identified inflammatory biomarkers which indicate whether the brain has suffered injury.